|
Recent Developments |
|
01-OCT-15
SMS Pharmaceuticals, engaged in the manufacture of active pharmaceutical ingredients and drug intermediates, announced that the company to consider stock split i.e. sub-division of equity shares as per ratio finalize by the Board.
27-APR-15
SMS Pharmaceuticals , a manufacture of active pharmaceutical ingredients and drug intermediates, announced that USFDA inspection to the Unit-VII located at Kandivalasa Village, Pusapatirega Mandal... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2014(9) | 31-Mar-2014 (12) | 31-Mar-2013 (12) | | Net sales | 3898.04 | 4819.78 | 2399.34 | | Other Income | 104.88 | 15.24 | 16.19 | | Total Income | 4002.92 | 4835.02 | 2415.53 | | Cost of goods sold | 3626.08 | 4608.69 | 2777.02 | | OPBDIT | 376.84 | 226.33 | -361.49 | | PAT | 249.00 | 203.85 | 253.25 | | Gross Block | - | - | - | | Equity capital | 84.65 | 84.65 | 100.15 | | EPS (Rs.) | - | 23.06 | 0.00 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 6.59 - 12.05 | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 9.4 | 4.7 | -15.0 | | Net margin (% of OI) | 6.2 | 4.2 | 10.5 |
|
|
Detailed Financials
|
|
|
|
|
